Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novelion Therapeutics Inc (NASDAQ:NVLN)

Delayed Data
As of Feb 17
 -0.05 / -0.46%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Novelion Therapeutics Inc have a median target of 11.88, with a high estimate of 13.75 and a low estimate of 10.00. The median estimate represents a +10.16% increase from the last price of 10.78.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Hold stock in Novelion Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Feb 23

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 38.18%
Growthannually -1.14%


Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.